Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-03 3:15 pm Sale | 13G | PDF Solutions, Inc. PDFS | Cowen Prime Advisors LLC | 1,431,404 4% | -311,321![]() (-17.86%) | View |
2023-02-03 3:13 pm Sale | 13G | Nephros, Inc. NEPH | Cowen Prime Advisors LLC | 0 0% | -633,050![]() (Position Closed) | View |
2023-02-03 3:11 pm Sale | 13G | HTG Molecular Diagnostics, Inc. HTGM | Cowen Prime Advisors LLC | 0 0% | -593,133![]() (Position Closed) | View |
2023-01-06 12:04 pm Sale | 13G | Nephros, Inc. NEPH | Intelligent Fanatics Capital Management LLC | 0 0% | -525![]() (Position Closed) | View |
2022-02-28 12:05 pm Purchase | 13G | Nephros, Inc. NEPH | Intelligent Fanatics Capital Management LLC | 525 5.12% | 525![]() (New Position) | View |
2022-02-10 2:19 pm Sale | 13G | PDF Solutions, Inc. PDFS | Cowen Prime Services LLC | 0 0% | -1,624,378![]() (Position Closed) | View |
2022-02-10 2:19 pm Sale | 13G | Research Solutions, Inc. RSSS | Cowen Prime Services LLC | 0 0% | -1,562,200![]() (Position Closed) | View |
2022-02-10 2:18 pm Sale | 13G | Nephros, Inc. NEPH | Cowen Prime Services LLC | 0 0% | -575,077![]() (Position Closed) | View |
2022-02-10 2:18 pm Sale | 13G | Iteris, Inc. ITI | Cowen Prime Services LLC | 0 0% | -2,140,092![]() (Position Closed) | View |
2022-02-10 2:17 pm Sale | 13G | HTG Molecular Diagnostics, Inc. HTGM | Cowen Prime Services LLC | 0 0% | -3,573,000![]() (Position Closed) | View |
2022-02-09 12:35 pm Purchase | 13G | Nephros, Inc. NEPH | Cowen Prime Advisors LLC | 633,050 6% | 633,050![]() (New Position) | View |
2022-02-08 2:17 pm Sale | 13G | Nephros, Inc. NEPH | Samjo Capital LLC | 425,000 4.2% | -125,000![]() (-22.73%) | View |
2021-06-11 12:51 pm Purchase | 13D | Nephros, Inc. NEPH | Evans Daron | 478,874 4.7% | 5,810![]() (+1.23%) | View |
2021-01-27 11:16 am Purchase | 13G | Nephros, Inc. NEPH | Cowen Prime Services LLC | 575,077 6% | 575,077![]() (New Position) | View |
2020-10-26 4:42 pm Sale | 13D | Nephros, Inc. NEPH | WEXFORD CAPITAL LP | 3,673,463 36.79% | -27,560,568![]() (-88.24%) | View |
2020-10-21 4:44 pm Purchase | 13G | Nephros, Inc. NEPH | Samjo Capital LLC | 550,000 5.6% | 550,000![]() (New Position) | View |
2020-10-21 1:15 pm Sale | 13D | Nephros, Inc. NEPH | PESSIN NORMAN H | 489,435 5% | -3,465,490![]() (-87.62%) | View |
2020-04-08 4:30 pm Purchase | 13D | Nephros, Inc. NEPH | Evans Daron | 473,064 5.1% | 473,064![]() (New Position) | View |
2019-05-20 09:29 am Purchase | 13D | Nephros, Inc. NEPH | PESSIN NORMAN H | 3,954,925 5.7% | 1,222,218![]() (+44.73%) | View |